AbbVie Earnings Edge Past Views With Stock Right At Buy Point

AbbVie stock fell Friday after the pharma company reported adjusted earnings of $3.11 per share on $13.96 billion in second-quarter sales.


On average, analysts polled by FactSet expected AbbVie (ABBV) to earn $3.08 a share on $13.63 billion in sales.

In the year-earlier period, AbbVie earned $2.34 per share and reported $10.43 billion in sales.

For the year, AbbVie expects per-share earnings of $12.52-$12.62 vs. its prior target of 12.37-$12.57, lifting the midpoint by a dime to $12.57. Analysts called for profit of $12.60 per share and $55.91 billion in sales.

In midday trading on the stock market today, AbbVie stock fell 1.1% near 117.57. Shares had closed Thursday just above 118.38 buy point out of a flat base, according to

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Why Merck Stock Might Sacrifice Its Breakout Despite Beating Sales Forecasts

Annovis Bio Stock Crashes After Much-Hyped Alzheimer’s Drug Flops In Midstage Test

IBD’s Leaderboard Is Turning 10! Help Us Celebrate

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks

William Murphy

William Murphy

Related post